Breaking Boundaries in Science and in Life: How Yasmin Hurd, PhD, is Paving New Ground for Addiction Treatment
Neuroscientist Yasmin Hurd, PhD, has a natural way of connecting with people. Whether through her many research publications, a TED Talk, or during a virtual meeting with two team members of Mount Sinai Innovation Partners (MSIP), it is easy to be inspired …
Meet Charles Mobbs, PhD, of Team Gilga-Med: the Winner of the Mount Sinai Pitch Challenge 2021
Charles Mobbs, PhD, Professor in the Departments of Geriatrics and Palliative Care, Neuroscience, and Medicine at the Icahn School of Medicine at Mount Sinai, won the Mount Sinai Pitch Challenge on May 5 by presenting the healthcare startup Gilga-Med. Read the Q&A …
Pitch Challenge 2021 Contestant George Foulard, MD, Discusses Platform for Hospital Capacity Management
George Foulard, MD, a Diagnostic Radiology Resident at The Mount Sinai Hospital, is presenting Bedboard at the Mount Sinai Pitch Challenge on May 5. Bedboard, an information technology platform that matches discharged or transferred patients with proper care settings, won the Innovation …
Robert J. Desnick , MD, E. Premkumar Reddy, PhD, and Edward Schuchman, PhD, Elected to the National Academy of Inventors
Mount Sinai researchers Robert J. Desnick, MD, PhD, E. Premkumar (Prem) Reddy, PhD, and Edward Schuchman, PhD, became Fellows of the National Academy of Inventors (NAI). The National Academy of Inventors (NAI) is a prestigious organization, comprised of international universities, and governmental …
MSIP Honors Inventors for their Exemplary Work in Developing Mount Sinai’s COVID-19 Antibody Test
At the Innovation Awards Ceremony on December 8, Mount Sinai Innovation Partners (MSIP) presented the award for Inventor of the Year to eight individuals whose efforts led to the development of multiple diagnostic tests for the detection of antibodies against the COVID-19 …
Next-gen antibody tests promise more answers to Covid-19 questions
MedCity News The new tests can open a window into the duration of immunity and to the antibody levels needed to sustain it. But first, a universal standard is needed to ensure results are comparable between tests. The next generation of antibody …
FDA clears a ‘new generation’ of Covid antibody test designed to tell how well someone is protected against the virus
CNBC — Wednesday, November 25, 2020 The FDA on Wednesday authorized one of the first Covid-19 tests that measures the amount of neutralizing antibodies produced by the body’s immune system after exposure to the virus — a “new generation” of coronavirus test that …
Mount Sinai Researchers Streamline Patient Data to Find Patterns in COVID-19 Patients
With the influx of patient data resulting from the SARS-CoV-2 pandemic, the Mount Sinai COVID Informatics Center is collaborating with London-based software company Clinithink to uncover key findings that can enable better treatment methods for COVID-19 patients. Clinithink’s artificial intelligence platform, CLiX, …
Live Interview: Trellus Health Co-Founders Marla Dubinsky, MD and Laurie Keefer, PhD
Tune in to The Innovation Cafe, MSIP’s LinkedIn Live interview series, where Marla Dubinsky, MD and Laurie Keefer, PhD, of the Susan and Leonard Feinstein Inflammatory Bowel Disease (IBD) Clinical Center at Mount Sinai discussed how they developed Trellus Health – the …